We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
The X-ray Crystal Structure of Mannose-Binding Lectin-Associated Serine Proteinase-3
News

The X-ray Crystal Structure of Mannose-Binding Lectin-Associated Serine Proteinase-3

The X-ray Crystal Structure of Mannose-Binding Lectin-Associated Serine Proteinase-3
News

The X-ray Crystal Structure of Mannose-Binding Lectin-Associated Serine Proteinase-3

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "The X-ray Crystal Structure of Mannose-Binding Lectin-Associated Serine Proteinase-3"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SUMMARY
The mannose-binding lectin associatedprotease-3 (MASP-3) is a member of the lectin  pathway of the complement system, a key  component of human innate and active  immunity. Mutations in MASP-3 have  recently been found to be associated with  Carnevale, Mingarelli, Malpuech and Michels (3MC) syndrome, a severe developmental  disorder manifested by cleft palate,  intellectual disability and skeletal  abnormalities. However, the molecular basis  for MASP-3 function remains to be  understood. Here we characterise the  substrate specificity of MASP-3 by screening  against a combinatorial peptide substrate  library. Through this approach, we  successfully identified a peptide substrate that  was 20-fold more efficiently cleaved than any  other identified to date. Further, we  demonstrated that mutant forms of the  enzyme associated with 3MC syndrome were  completely inactive against this substrate. To  address the structural basis for this defect, we  determined the 2.6 Å structure of the  zymogen form of the G666E mutant of  MASP-3. These data reveal that the mutation disrupts the active site and perturbs the  position of the catalytic serine residue.  Together, these insights into the function of  MASP-3 reveal how a mutation in this enzyme  causes it to be inactive and thus contribute to  the 3MC syndrome.

This article was published online in The Journal of Biological Chemistry and is free to access.

Advertisement